nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbachol—PLA2G4A—Epirubicin—peripheral nervous system neoplasm	0.699	1	CbGbCtD
Carbachol—Succinylcholine—BCHE—peripheral nervous system neoplasm	0.0054	0.611	CrCbGaD
Carbachol—Choline—BCHE—peripheral nervous system neoplasm	0.00344	0.389	CrCbGaD
Carbachol—Ulcer—Dactinomycin—peripheral nervous system neoplasm	0.00212	0.00758	CcSEcCtD
Carbachol—Phlebitis—Tretinoin—peripheral nervous system neoplasm	0.00207	0.0074	CcSEcCtD
Carbachol—Phlebitis—Isotretinoin—peripheral nervous system neoplasm	0.00207	0.0074	CcSEcCtD
Carbachol—Extravasation—Vincristine—peripheral nervous system neoplasm	0.00206	0.00735	CcSEcCtD
Carbachol—Necrosis—Cisplatin—peripheral nervous system neoplasm	0.00202	0.00722	CcSEcCtD
Carbachol—Abscess—Cisplatin—peripheral nervous system neoplasm	0.002	0.00716	CcSEcCtD
Carbachol—Ulcer—Alitretinoin—peripheral nervous system neoplasm	0.00197	0.00703	CcSEcCtD
Carbachol—Necrosis—Etoposide—peripheral nervous system neoplasm	0.00185	0.00662	CcSEcCtD
Carbachol—Tenderness—Cisplatin—peripheral nervous system neoplasm	0.00182	0.0065	CcSEcCtD
Carbachol—Extravasation—Cisplatin—peripheral nervous system neoplasm	0.00182	0.0065	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Tretinoin—peripheral nervous system neoplasm	0.00178	0.00637	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Isotretinoin—peripheral nervous system neoplasm	0.00178	0.00637	CcSEcCtD
Carbachol—Hyponatraemia—Melphalan—peripheral nervous system neoplasm	0.00177	0.00631	CcSEcCtD
Carbachol—Phlebitis—Dactinomycin—peripheral nervous system neoplasm	0.00169	0.00604	CcSEcCtD
Carbachol—Ulcer—Cisplatin—peripheral nervous system neoplasm	0.00168	0.00599	CcSEcCtD
Carbachol—Extravasation—Etoposide—peripheral nervous system neoplasm	0.00167	0.00595	CcSEcCtD
Carbachol—Cramp muscle—Topotecan—peripheral nervous system neoplasm	0.00162	0.00578	CcSEcCtD
Carbachol—Phlebitis—Alitretinoin—peripheral nervous system neoplasm	0.00157	0.0056	CcSEcCtD
Carbachol—Hyperkalaemia—Cisplatin—peripheral nervous system neoplasm	0.00156	0.00557	CcSEcCtD
Carbachol—Asthma—Isotretinoin—peripheral nervous system neoplasm	0.00154	0.00551	CcSEcCtD
Carbachol—Asthma—Tretinoin—peripheral nervous system neoplasm	0.00154	0.00551	CcSEcCtD
Carbachol—Ulcer—Etoposide—peripheral nervous system neoplasm	0.00154	0.00549	CcSEcCtD
Carbachol—Venous thrombosis—Epirubicin—peripheral nervous system neoplasm	0.00151	0.00539	CcSEcCtD
Carbachol—Sweating increased—Tretinoin—peripheral nervous system neoplasm	0.0015	0.00536	CcSEcCtD
Carbachol—Sweating increased—Isotretinoin—peripheral nervous system neoplasm	0.0015	0.00536	CcSEcCtD
Carbachol—Abdominal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00148	0.00528	CcSEcCtD
Carbachol—Abdominal discomfort—Tretinoin—peripheral nervous system neoplasm	0.00148	0.00528	CcSEcCtD
Carbachol—Venous thrombosis—Doxorubicin—peripheral nervous system neoplasm	0.0014	0.00499	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Alitretinoin—peripheral nervous system neoplasm	0.00135	0.00483	CcSEcCtD
Carbachol—Phlebitis—Cisplatin—peripheral nervous system neoplasm	0.00134	0.00478	CcSEcCtD
Carbachol—Sweating—Topotecan—peripheral nervous system neoplasm	0.00133	0.00474	CcSEcCtD
Carbachol—Sweating—Tretinoin—peripheral nervous system neoplasm	0.00132	0.00471	CcSEcCtD
Carbachol—Sweating—Isotretinoin—peripheral nervous system neoplasm	0.00132	0.00471	CcSEcCtD
Carbachol—Hyponatraemia—Vincristine—peripheral nervous system neoplasm	0.00131	0.00467	CcSEcCtD
Carbachol—Phlebitis—Etoposide—peripheral nervous system neoplasm	0.00122	0.00437	CcSEcCtD
Carbachol—Asthma—Alitretinoin—peripheral nervous system neoplasm	0.00117	0.00417	CcSEcCtD
Carbachol—Hyponatraemia—Cisplatin—peripheral nervous system neoplasm	0.00116	0.00413	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Cisplatin—peripheral nervous system neoplasm	0.00115	0.00411	CcSEcCtD
Carbachol—Flushing—Tretinoin—peripheral nervous system neoplasm	0.00114	0.00409	CcSEcCtD
Carbachol—Flushing—Isotretinoin—peripheral nervous system neoplasm	0.00114	0.00409	CcSEcCtD
Carbachol—Sweating increased—Alitretinoin—peripheral nervous system neoplasm	0.00114	0.00407	CcSEcCtD
Carbachol—Flushing—Melphalan—peripheral nervous system neoplasm	0.00113	0.00404	CcSEcCtD
Carbachol—Abdominal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00112	0.004	CcSEcCtD
Carbachol—Arrhythmia—Tretinoin—peripheral nervous system neoplasm	0.0011	0.00394	CcSEcCtD
Carbachol—Arrhythmia—Isotretinoin—peripheral nervous system neoplasm	0.0011	0.00394	CcSEcCtD
Carbachol—Arrhythmia—Melphalan—peripheral nervous system neoplasm	0.00109	0.00389	CcSEcCtD
Carbachol—Flatulence—Isotretinoin—peripheral nervous system neoplasm	0.00106	0.00378	CcSEcCtD
Carbachol—Flatulence—Tretinoin—peripheral nervous system neoplasm	0.00106	0.00378	CcSEcCtD
Carbachol—Muscle spasms—Topotecan—peripheral nervous system neoplasm	0.00104	0.00372	CcSEcCtD
Carbachol—Necrosis—Epirubicin—peripheral nervous system neoplasm	0.00104	0.00371	CcSEcCtD
Carbachol—Cramp muscle—Cisplatin—peripheral nervous system neoplasm	0.00104	0.0037	CcSEcCtD
Carbachol—Abscess—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00368	CcSEcCtD
Carbachol—Stinging—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00359	CcSEcCtD
Carbachol—Sweating—Alitretinoin—peripheral nervous system neoplasm	0.000998	0.00357	CcSEcCtD
Carbachol—Sweating increased—Cisplatin—peripheral nervous system neoplasm	0.000969	0.00346	CcSEcCtD
Carbachol—Syncope—Tretinoin—peripheral nervous system neoplasm	0.000963	0.00344	CcSEcCtD
Carbachol—Syncope—Isotretinoin—peripheral nervous system neoplasm	0.000963	0.00344	CcSEcCtD
Carbachol—Sweating—Vincristine—peripheral nervous system neoplasm	0.000962	0.00344	CcSEcCtD
Carbachol—Necrosis—Doxorubicin—peripheral nervous system neoplasm	0.00096	0.00343	CcSEcCtD
Carbachol—Abdominal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000954	0.00341	CcSEcCtD
Carbachol—Abscess—Doxorubicin—peripheral nervous system neoplasm	0.000953	0.0034	CcSEcCtD
Carbachol—Cramp muscle—Etoposide—peripheral nervous system neoplasm	0.00095	0.00339	CcSEcCtD
Carbachol—Loss of consciousness—Tretinoin—peripheral nervous system neoplasm	0.000944	0.00337	CcSEcCtD
Carbachol—Loss of consciousness—Isotretinoin—peripheral nervous system neoplasm	0.000944	0.00337	CcSEcCtD
Carbachol—Flushing—Dactinomycin—peripheral nervous system neoplasm	0.000936	0.00334	CcSEcCtD
Carbachol—Extravasation—Epirubicin—peripheral nervous system neoplasm	0.000934	0.00334	CcSEcCtD
Carbachol—Stinging—Doxorubicin—peripheral nervous system neoplasm	0.00093	0.00332	CcSEcCtD
Carbachol—Sweating increased—Etoposide—peripheral nervous system neoplasm	0.000888	0.00317	CcSEcCtD
Carbachol—Infection—Topotecan—peripheral nervous system neoplasm	0.000878	0.00314	CcSEcCtD
Carbachol—Infection—Tretinoin—peripheral nervous system neoplasm	0.000871	0.00311	CcSEcCtD
Carbachol—Infection—Isotretinoin—peripheral nervous system neoplasm	0.000871	0.00311	CcSEcCtD
Carbachol—Flushing—Alitretinoin—peripheral nervous system neoplasm	0.000868	0.0031	CcSEcCtD
Carbachol—Extravasation—Doxorubicin—peripheral nervous system neoplasm	0.000864	0.00309	CcSEcCtD
Carbachol—Shock—Isotretinoin—peripheral nervous system neoplasm	0.000862	0.00308	CcSEcCtD
Carbachol—Shock—Tretinoin—peripheral nervous system neoplasm	0.000862	0.00308	CcSEcCtD
Carbachol—Ulcer—Epirubicin—peripheral nervous system neoplasm	0.000861	0.00308	CcSEcCtD
Carbachol—Infection—Melphalan—peripheral nervous system neoplasm	0.000859	0.00307	CcSEcCtD
Carbachol—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.000854	0.00305	CcSEcCtD
Carbachol—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.000847	0.00303	CcSEcCtD
Carbachol—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.000847	0.00303	CcSEcCtD
Carbachol—Arrhythmia—Alitretinoin—peripheral nervous system neoplasm	0.000835	0.00298	CcSEcCtD
Carbachol—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.000819	0.00293	CcSEcCtD
Carbachol—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.000819	0.00293	CcSEcCtD
Carbachol—Hypotension—Melphalan—peripheral nervous system neoplasm	0.000808	0.00289	CcSEcCtD
Carbachol—Flatulence—Alitretinoin—peripheral nervous system neoplasm	0.000802	0.00287	CcSEcCtD
Carbachol—Hyperkalaemia—Epirubicin—peripheral nervous system neoplasm	0.0008	0.00286	CcSEcCtD
Carbachol—Ulcer—Doxorubicin—peripheral nervous system neoplasm	0.000797	0.00285	CcSEcCtD
Carbachol—Salivary hypersecretion—Epirubicin—peripheral nervous system neoplasm	0.000791	0.00283	CcSEcCtD
Carbachol—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.000778	0.00278	CcSEcCtD
Carbachol—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.000771	0.00276	CcSEcCtD
Carbachol—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.000771	0.00276	CcSEcCtD
Carbachol—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.000761	0.00272	CcSEcCtD
Carbachol—Pain—Topotecan—peripheral nervous system neoplasm	0.000756	0.0027	CcSEcCtD
Carbachol—Pain—Tretinoin—peripheral nervous system neoplasm	0.000749	0.00268	CcSEcCtD
Carbachol—Pain—Isotretinoin—peripheral nervous system neoplasm	0.000749	0.00268	CcSEcCtD
Carbachol—Hyperkalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000741	0.00265	CcSEcCtD
Carbachol—Pain—Melphalan—peripheral nervous system neoplasm	0.00074	0.00264	CcSEcCtD
Carbachol—Flushing—Cisplatin—peripheral nervous system neoplasm	0.000739	0.00264	CcSEcCtD
Carbachol—Salivary hypersecretion—Doxorubicin—peripheral nervous system neoplasm	0.000732	0.00262	CcSEcCtD
Carbachol—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.00073	0.00261	CcSEcCtD
Carbachol—CHRM3—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.000726	0.0612	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.000719	0.0606	CbGpPWpGaD
Carbachol—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.000715	0.00256	CcSEcCtD
Carbachol—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000712	0.00254	CcSEcCtD
Carbachol—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.000712	0.00254	CcSEcCtD
Carbachol—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000698	0.0025	CcSEcCtD
Carbachol—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000698	0.0025	CcSEcCtD
Carbachol—PLA2G4A—PDGF Pathway—COX2—peripheral nervous system neoplasm	0.000693	0.0584	CbGpPWpGaD
Carbachol—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000693	0.00248	CcSEcCtD
Carbachol—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000693	0.00248	CcSEcCtD
Carbachol—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000693	0.00248	CcSEcCtD
Carbachol—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000693	0.00248	CcSEcCtD
Carbachol—Phlebitis—Epirubicin—peripheral nervous system neoplasm	0.000686	0.00245	CcSEcCtD
Carbachol—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.000683	0.00244	CcSEcCtD
Carbachol—Flushing—Etoposide—peripheral nervous system neoplasm	0.000677	0.00242	CcSEcCtD
Carbachol—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000667	0.00238	CcSEcCtD
Carbachol—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00066	0.00236	CcSEcCtD
Carbachol—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000653	0.00233	CcSEcCtD
Carbachol—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000642	0.00229	CcSEcCtD
Carbachol—Infection—Vincristine—peripheral nervous system neoplasm	0.000636	0.00227	CcSEcCtD
Carbachol—Phlebitis—Doxorubicin—peripheral nervous system neoplasm	0.000635	0.00227	CcSEcCtD
Carbachol—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000621	0.00222	CcSEcCtD
Carbachol—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000619	0.00221	CcSEcCtD
Carbachol—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000613	0.00219	CcSEcCtD
Carbachol—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000611	0.00218	CcSEcCtD
Carbachol—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000604	0.00216	CcSEcCtD
Carbachol—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.0006	0.00214	CcSEcCtD
Carbachol—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.0006	0.00214	CcSEcCtD
Carbachol—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000598	0.00214	CcSEcCtD
Carbachol—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	0.000594	0.00212	CcSEcCtD
Carbachol—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000592	0.00211	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000591	0.00211	CcSEcCtD
Carbachol—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000585	0.00209	CcSEcCtD
Carbachol—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000584	0.00209	CcSEcCtD
Carbachol—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00058	0.00207	CcSEcCtD
Carbachol—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00058	0.00207	CcSEcCtD
Carbachol—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000568	0.00203	CcSEcCtD
Carbachol—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000566	0.00202	CcSEcCtD
Carbachol—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000566	0.00202	CcSEcCtD
Carbachol—Infection—Cisplatin—peripheral nervous system neoplasm	0.000562	0.00201	CcSEcCtD
Carbachol—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000562	0.00201	CcSEcCtD
Carbachol—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000558	0.00199	CcSEcCtD
Carbachol—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000557	0.00199	CcSEcCtD
Carbachol—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000557	0.00199	CcSEcCtD
Carbachol—Rash—Topotecan—peripheral nervous system neoplasm	0.000557	0.00199	CcSEcCtD
Carbachol—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000557	0.00199	CcSEcCtD
Carbachol—Headache—Topotecan—peripheral nervous system neoplasm	0.000553	0.00198	CcSEcCtD
Carbachol—Rash—Tretinoin—peripheral nervous system neoplasm	0.000553	0.00197	CcSEcCtD
Carbachol—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000553	0.00197	CcSEcCtD
Carbachol—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000552	0.00197	CcSEcCtD
Carbachol—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000552	0.00197	CcSEcCtD
Carbachol—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00055	0.00197	CcSEcCtD
Carbachol—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.000549	0.00196	CcSEcCtD
Carbachol—Headache—Tretinoin—peripheral nervous system neoplasm	0.000549	0.00196	CcSEcCtD
Carbachol—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000549	0.00196	CcSEcCtD
Carbachol—Pain—Vincristine—peripheral nervous system neoplasm	0.000547	0.00196	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000547	0.00195	CcSEcCtD
Carbachol—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000547	0.00195	CcSEcCtD
Carbachol—Rash—Melphalan—peripheral nervous system neoplasm	0.000545	0.00195	CcSEcCtD
Carbachol—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000545	0.00195	CcSEcCtD
Carbachol—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000529	0.00189	CcSEcCtD
Carbachol—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000525	0.00188	CcSEcCtD
Carbachol—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000525	0.00188	CcSEcCtD
Carbachol—Nausea—Topotecan—peripheral nervous system neoplasm	0.000525	0.00187	CcSEcCtD
Carbachol—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000521	0.00186	CcSEcCtD
Carbachol—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000521	0.00186	CcSEcCtD
Carbachol—Infection—Etoposide—peripheral nervous system neoplasm	0.000515	0.00184	CcSEcCtD
Carbachol—Nausea—Melphalan—peripheral nervous system neoplasm	0.000514	0.00184	CcSEcCtD
Carbachol—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000511	0.00183	CcSEcCtD
Carbachol—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000506	0.00181	CcSEcCtD
Carbachol—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000506	0.00181	CcSEcCtD
Carbachol—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000501	0.00179	CcSEcCtD
Carbachol—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00049	0.00175	CcSEcCtD
Carbachol—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000484	0.00173	CcSEcCtD
Carbachol—Pain—Cisplatin—peripheral nervous system neoplasm	0.000484	0.00173	CcSEcCtD
Carbachol—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000473	0.00169	CcSEcCtD
Carbachol—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000455	0.00163	CcSEcCtD
Carbachol—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000454	0.00162	CcSEcCtD
Carbachol—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000452	0.00161	CcSEcCtD
Carbachol—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000447	0.0016	CcSEcCtD
Carbachol—Pain—Etoposide—peripheral nervous system neoplasm	0.000443	0.00158	CcSEcCtD
Carbachol—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000439	0.00157	CcSEcCtD
Carbachol—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000438	0.00156	CcSEcCtD
Carbachol—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000437	0.00156	CcSEcCtD
Carbachol—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000426	0.00152	CcSEcCtD
Carbachol—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000423	0.00151	CcSEcCtD
Carbachol—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000422	0.00151	CcSEcCtD
Carbachol—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000419	0.0015	CcSEcCtD
Carbachol—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000418	0.00149	CcSEcCtD
Carbachol—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000416	0.00149	CcSEcCtD
Carbachol—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00041	0.00146	CcSEcCtD
Carbachol—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00041	0.00146	CcSEcCtD
Carbachol—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000407	0.00145	CcSEcCtD
Carbachol—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000404	0.00144	CcSEcCtD
Carbachol—Rash—Vincristine—peripheral nervous system neoplasm	0.000404	0.00144	CcSEcCtD
Carbachol—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000403	0.00144	CcSEcCtD
Carbachol—Headache—Vincristine—peripheral nervous system neoplasm	0.000401	0.00143	CcSEcCtD
Carbachol—PLA2G4A—Platelet sensitization by LDL—PTPN11—peripheral nervous system neoplasm	0.000399	0.0336	CbGpPWpGaD
Carbachol—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000395	0.00141	CcSEcCtD
Carbachol—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000387	0.00138	CcSEcCtD
Carbachol—Nausea—Vincristine—peripheral nervous system neoplasm	0.00038	0.00136	CcSEcCtD
Carbachol—Flushing—Epirubicin—peripheral nervous system neoplasm	0.00038	0.00136	CcSEcCtD
Carbachol—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000365	0.00131	CcSEcCtD
Carbachol—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00036	0.00129	CcSEcCtD
Carbachol—Rash—Cisplatin—peripheral nervous system neoplasm	0.000357	0.00127	CcSEcCtD
Carbachol—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000357	0.00127	CcSEcCtD
Carbachol—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000355	0.00127	CcSEcCtD
Carbachol—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.00126	CcSEcCtD
Carbachol—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000351	0.00125	CcSEcCtD
Carbachol—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000343	0.00122	CcSEcCtD
Carbachol—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000342	0.00122	CcSEcCtD
Carbachol—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000338	0.00121	CcSEcCtD
Carbachol—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000336	0.0012	CcSEcCtD
Carbachol—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00033	0.00118	CcSEcCtD
Carbachol—Rash—Etoposide—peripheral nervous system neoplasm	0.000327	0.00117	CcSEcCtD
Carbachol—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000327	0.00117	CcSEcCtD
Carbachol—Headache—Etoposide—peripheral nervous system neoplasm	0.000325	0.00116	CcSEcCtD
Carbachol—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000325	0.00116	CcSEcCtD
Carbachol—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000319	0.00114	CcSEcCtD
Carbachol—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.00113	CcSEcCtD
Carbachol—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000313	0.00112	CcSEcCtD
Carbachol—Nausea—Etoposide—peripheral nervous system neoplasm	0.000308	0.0011	CcSEcCtD
Carbachol—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.00106	CcSEcCtD
Carbachol—PLA2G4A—Opioid Signalling—PPP3R1—peripheral nervous system neoplasm	0.000293	0.0247	CbGpPWpGaD
Carbachol—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.00103	CcSEcCtD
Carbachol—Infection—Epirubicin—peripheral nervous system neoplasm	0.000289	0.00103	CcSEcCtD
Carbachol—Shock—Epirubicin—peripheral nervous system neoplasm	0.000286	0.00102	CcSEcCtD
Carbachol—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000281	0.001	CcSEcCtD
Carbachol—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000272	0.00097	CcSEcCtD
Carbachol—CHRM2—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.000268	0.0226	CbGpPWpGaD
Carbachol—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000954	CcSEcCtD
Carbachol—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000945	CcSEcCtD
Carbachol—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000929	CcSEcCtD
Carbachol—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000914	CcSEcCtD
Carbachol—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000898	CcSEcCtD
Carbachol—Pain—Epirubicin—peripheral nervous system neoplasm	0.000249	0.000888	CcSEcCtD
Carbachol—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000846	CcSEcCtD
Carbachol—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.000822	CcSEcCtD
Carbachol—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000821	CcSEcCtD
Carbachol—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000821	CcSEcCtD
Carbachol—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.00076	CcSEcCtD
Carbachol—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.00076	CcSEcCtD
Carbachol—PLA2G4A—PDGF Pathway—PTPN11—peripheral nervous system neoplasm	0.000205	0.0173	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000202	0.017	CbGpPWpGaD
Carbachol—PLA2G4A—Glycerophospholipid biosynthesis—BCHE—peripheral nervous system neoplasm	0.000201	0.0169	CbGpPWpGaD
Carbachol—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000199	0.00071	CcSEcCtD
Carbachol—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000687	CcSEcCtD
Carbachol—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000185	0.00066	CcSEcCtD
Carbachol—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000657	CcSEcCtD
Carbachol—Rash—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000655	CcSEcCtD
Carbachol—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000654	CcSEcCtD
Carbachol—Headache—Epirubicin—peripheral nervous system neoplasm	0.000182	0.00065	CcSEcCtD
Carbachol—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000635	CcSEcCtD
Carbachol—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000617	CcSEcCtD
Carbachol—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000611	CcSEcCtD
Carbachol—PLA2G4A—Platelet homeostasis—GNAS—peripheral nervous system neoplasm	0.00017	0.0143	CbGpPWpGaD
Carbachol—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000606	CcSEcCtD
Carbachol—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000605	CcSEcCtD
Carbachol—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000602	CcSEcCtD
Carbachol—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000571	CcSEcCtD
Carbachol—CHRNA2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000147	0.0124	CbGpPWpGaD
Carbachol—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—PTPN11—peripheral nervous system neoplasm	0.000143	0.0121	CbGpPWpGaD
Carbachol—PLA2G4A—Phospholipid metabolism—BCHE—peripheral nervous system neoplasm	0.00014	0.0118	CbGpPWpGaD
Carbachol—CHRM1—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.000129	0.0109	CbGpPWpGaD
Carbachol—CHRM3—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.000128	0.0108	CbGpPWpGaD
Carbachol—PLA2G4A—p38 MAPK Signaling Pathway—MYC—peripheral nervous system neoplasm	0.000128	0.0108	CbGpPWpGaD
Carbachol—CHRM3—Regulation of insulin secretion—SLC2A1—peripheral nervous system neoplasm	0.000128	0.0107	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000122	0.0103	CbGpPWpGaD
Carbachol—PLA2G4A—Platelet homeostasis—PTPN11—peripheral nervous system neoplasm	0.000118	0.00993	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.000115	0.00971	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.000115	0.00968	CbGpPWpGaD
Carbachol—CHRNA2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000113	0.00948	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—peripheral nervous system neoplasm	0.000103	0.00867	CbGpPWpGaD
Carbachol—CHRM3—Regulation of insulin secretion—GNAS—peripheral nervous system neoplasm	0.000103	0.00865	CbGpPWpGaD
Carbachol—PLA2G4A—p38 MAPK Signaling Pathway—HRAS—peripheral nervous system neoplasm	0.000101	0.00848	CbGpPWpGaD
Carbachol—CHRM3—Integration of energy metabolism—SLC2A1—peripheral nervous system neoplasm	0.0001	0.00845	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	9.9e-05	0.00834	CbGpPWpGaD
Carbachol—PLA2G4A—AGE/RAGE pathway—CASP3—peripheral nervous system neoplasm	9.66e-05	0.00814	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	9.03e-05	0.0076	CbGpPWpGaD
Carbachol—PLA2G4A—PDGF Pathway—HRAS—peripheral nervous system neoplasm	9.03e-05	0.0076	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	8.53e-05	0.00719	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	8.51e-05	0.00717	CbGpPWpGaD
Carbachol—PLA2G4A—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	8.43e-05	0.0071	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	8.42e-05	0.0071	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	8.27e-05	0.00696	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	8.13e-05	0.00685	CbGpPWpGaD
Carbachol—PLA2G4A—PDGFR-beta signaling pathway—PTPN11—peripheral nervous system neoplasm	8.08e-05	0.00681	CbGpPWpGaD
Carbachol—CHRM3—Integration of energy metabolism—GNAS—peripheral nervous system neoplasm	8.07e-05	0.0068	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.03e-05	0.00676	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	7.72e-05	0.00651	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	7.08e-05	0.00596	CbGpPWpGaD
Carbachol—PLA2G4A—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	7.02e-05	0.00591	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—NTS—peripheral nervous system neoplasm	6.5e-05	0.00547	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—NTS—peripheral nervous system neoplasm	6.48e-05	0.00546	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—NTS—peripheral nervous system neoplasm	6.41e-05	0.0054	CbGpPWpGaD
Carbachol—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—HRAS—peripheral nervous system neoplasm	6.31e-05	0.00532	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—CD55—peripheral nervous system neoplasm	6.23e-05	0.00525	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—CD55—peripheral nervous system neoplasm	6.21e-05	0.00523	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—CD55—peripheral nervous system neoplasm	6.15e-05	0.00518	CbGpPWpGaD
Carbachol—PLA2G4A—Endothelins—HRAS—peripheral nervous system neoplasm	6.15e-05	0.00518	CbGpPWpGaD
Carbachol—CHRM1—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	6.07e-05	0.00512	CbGpPWpGaD
Carbachol—CHRM3—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	6.05e-05	0.0051	CbGpPWpGaD
Carbachol—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	5.99e-05	0.00505	CbGpPWpGaD
Carbachol—CHRM1—Circadian rythm related genes—TH—peripheral nervous system neoplasm	5.85e-05	0.00493	CbGpPWpGaD
Carbachol—CHRM1—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	5.79e-05	0.00488	CbGpPWpGaD
Carbachol—CHRM3—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	5.77e-05	0.00486	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	5.77e-05	0.00486	CbGpPWpGaD
Carbachol—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—AKT1—peripheral nervous system neoplasm	5.57e-05	0.00469	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—NTS—peripheral nervous system neoplasm	5.55e-05	0.00467	CbGpPWpGaD
Carbachol—PLA2G4A—Endothelins—AKT1—peripheral nervous system neoplasm	5.43e-05	0.00457	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.42e-05	0.00457	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—CD55—peripheral nervous system neoplasm	5.32e-05	0.00448	CbGpPWpGaD
Carbachol—PLA2G4A—AGE/RAGE pathway—AKT1—peripheral nervous system neoplasm	5.23e-05	0.00441	CbGpPWpGaD
Carbachol—CHRM1—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	5.21e-05	0.00439	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	5.18e-05	0.00436	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	5.16e-05	0.00435	CbGpPWpGaD
Carbachol—PLA2G4A—PDGFR-beta signaling pathway—NRAS—peripheral nervous system neoplasm	4.86e-05	0.00409	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.81e-05	0.00405	CbGpPWpGaD
Carbachol—CHRM2—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	4.76e-05	0.00401	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—IFNB1—peripheral nervous system neoplasm	4.69e-05	0.00395	CbGpPWpGaD
Carbachol—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	4.58e-05	0.00386	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	4.55e-05	0.00383	CbGpPWpGaD
Carbachol—PLA2G4A—PDGFR-beta signaling pathway—MYC—peripheral nervous system neoplasm	4.53e-05	0.00381	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.51e-05	0.0038	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—KNG1—peripheral nervous system neoplasm	4.34e-05	0.00366	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	4.21e-05	0.00354	CbGpPWpGaD
Carbachol—CHRM2—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	4.16e-05	0.00351	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	4.13e-05	0.00348	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—GNS—peripheral nervous system neoplasm	3.92e-05	0.0033	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	3.88e-05	0.00327	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	3.83e-05	0.00323	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	3.82e-05	0.00322	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—GNAS—peripheral nervous system neoplasm	3.8e-05	0.0032	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	3.79e-05	0.00319	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—NME1—peripheral nervous system neoplasm	3.76e-05	0.00317	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	3.67e-05	0.00309	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	3.66e-05	0.00308	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	3.63e-05	0.00305	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—HGF—peripheral nervous system neoplasm	3.62e-05	0.00305	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—COX2—peripheral nervous system neoplasm	3.62e-05	0.00305	CbGpPWpGaD
Carbachol—PLA2G4A—PDGFR-beta signaling pathway—HRAS—peripheral nervous system neoplasm	3.55e-05	0.00299	CbGpPWpGaD
Carbachol—CHRNA2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	3.45e-05	0.0029	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	3.33e-05	0.00281	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—NTS—peripheral nervous system neoplasm	3.32e-05	0.0028	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	3.29e-05	0.00277	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—NTS—peripheral nervous system neoplasm	3.28e-05	0.00276	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.25e-05	0.00274	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	3.22e-05	0.00272	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	3.2e-05	0.00269	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—CD55—peripheral nervous system neoplasm	3.19e-05	0.00268	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	3.16e-05	0.00266	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	3.15e-05	0.00265	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CD55—peripheral nervous system neoplasm	3.14e-05	0.00265	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	3.14e-05	0.00264	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	2.92e-05	0.00246	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	2.91e-05	0.00245	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	2.88e-05	0.00243	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	2.88e-05	0.00243	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	2.78e-05	0.00234	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	2.77e-05	0.00234	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	2.75e-05	0.00231	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	2.65e-05	0.00223	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—PTPN11—peripheral nervous system neoplasm	2.64e-05	0.00222	CbGpPWpGaD
Carbachol—CHRNA2—Neuronal System—HRAS—peripheral nervous system neoplasm	2.64e-05	0.00222	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	2.55e-05	0.00215	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	2.55e-05	0.00214	CbGpPWpGaD
Carbachol—CHRM1—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	2.54e-05	0.00214	CbGpPWpGaD
Carbachol—CHRM3—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	2.53e-05	0.00213	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	2.53e-05	0.00213	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	2.52e-05	0.00212	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—VIP—peripheral nervous system neoplasm	2.52e-05	0.00212	CbGpPWpGaD
Carbachol—CHRM2—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	2.5e-05	0.00211	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	2.49e-05	0.0021	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	2.49e-05	0.0021	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—VIP—peripheral nervous system neoplasm	2.48e-05	0.00209	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—ENO2—peripheral nervous system neoplasm	2.38e-05	0.002	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—GNS—peripheral nervous system neoplasm	2.35e-05	0.00198	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	2.33e-05	0.00196	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	2.33e-05	0.00196	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	2.3e-05	0.00194	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	2.29e-05	0.00193	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—NME1—peripheral nervous system neoplasm	2.25e-05	0.0019	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	2.24e-05	0.00188	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2.18e-05	0.00184	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—COX2—peripheral nervous system neoplasm	2.17e-05	0.00183	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—BCHE—peripheral nervous system neoplasm	2.01e-05	0.00169	CbGpPWpGaD
Carbachol—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.99e-05	0.00168	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.97e-05	0.00166	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.96e-05	0.00165	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.94e-05	0.00164	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.91e-05	0.00161	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	1.89e-05	0.00159	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.89e-05	0.00159	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—TH—peripheral nervous system neoplasm	1.89e-05	0.00159	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	1.89e-05	0.00159	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.88e-05	0.00159	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.86e-05	0.00157	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.72e-05	0.00145	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.65e-05	0.00139	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.64e-05	0.00139	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.63e-05	0.00137	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—NRAS—peripheral nervous system neoplasm	1.59e-05	0.00134	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—GNAS—peripheral nervous system neoplasm	1.54e-05	0.0013	CbGpPWpGaD
Carbachol—CHRM1—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	1.53e-05	0.00129	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.52e-05	0.00128	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—ABCB1—peripheral nervous system neoplasm	1.51e-05	0.00127	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.5e-05	0.00126	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.49e-05	0.00126	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.49e-05	0.00126	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.49e-05	0.00125	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.48e-05	0.00125	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.47e-05	0.00124	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.47e-05	0.00124	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.44e-05	0.00122	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.44e-05	0.00121	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.42e-05	0.0012	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—ENO2—peripheral nervous system neoplasm	1.42e-05	0.0012	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.4e-05	0.00118	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	1.38e-05	0.00117	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	1.38e-05	0.00116	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.38e-05	0.00116	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.37e-05	0.00116	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.36e-05	0.00115	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.31e-05	0.0011	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.31e-05	0.0011	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.29e-05	0.00109	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.29e-05	0.00109	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—TP53—peripheral nervous system neoplasm	1.21e-05	0.00102	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—BCHE—peripheral nervous system neoplasm	1.2e-05	0.00101	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—HRAS—peripheral nervous system neoplasm	1.16e-05	0.000978	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.15e-05	0.000966	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—TH—peripheral nervous system neoplasm	1.13e-05	0.000952	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.03e-05	0.000872	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.03e-05	0.000869	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—AKT1—peripheral nervous system neoplasm	1.03e-05	0.000864	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.02e-05	0.000861	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—GNAS—peripheral nervous system neoplasm	9.23e-06	0.000777	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.11e-06	0.000767	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	9.11e-06	0.000767	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	9.08e-06	0.000765	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—ABCB1—peripheral nervous system neoplasm	9.06e-06	0.000763	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	8.99e-06	0.000757	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.95e-06	0.000754	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	8.85e-06	0.000746	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	8.82e-06	0.000743	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	8.74e-06	0.000736	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.44e-06	0.000711	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.41e-06	0.000708	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.33e-06	0.000702	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	7.74e-06	0.000652	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	7.72e-06	0.00065	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	7.64e-06	0.000644	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.07e-06	0.000596	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.67e-06	0.000561	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.42e-06	0.000541	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.89e-06	0.000496	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.48e-06	0.000461	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.46e-06	0.00046	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.4e-06	0.000455	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.38e-06	0.000453	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.38e-06	0.000453	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.36e-06	0.000452	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.31e-06	0.000447	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.01e-06	0.000422	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.25e-06	0.000358	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.24e-06	0.000357	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.2e-06	0.000354	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—AKT1—peripheral nervous system neoplasm	4.16e-06	0.00035	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.12e-06	0.000347	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.01e-06	0.000337	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.99e-06	0.000336	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.95e-06	0.000333	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.94e-06	0.000332	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.89e-06	0.000328	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.88e-06	0.000327	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.86e-06	0.000325	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.85e-06	0.000324	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.84e-06	0.000324	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.81e-06	0.000321	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.54e-06	0.000298	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.53e-06	0.000297	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.49e-06	0.000294	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.48e-06	0.000293	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.23e-06	0.000272	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.22e-06	0.000272	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.19e-06	0.000269	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.01e-06	0.000254	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MYC—peripheral nervous system neoplasm	3e-06	0.000253	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.97e-06	0.000251	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—AKT1—peripheral nervous system neoplasm	2.49e-06	0.00021	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.47e-06	0.000208	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.47e-06	0.000208	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.44e-06	0.000206	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.37e-06	0.000199	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.36e-06	0.000199	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.34e-06	0.000197	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.09e-06	0.000176	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.08e-06	0.000175	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.06e-06	0.000174	CbGpPWpGaD
